Takeda's ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1GuruFocus · Oct 14, 2026
Why a 10% Yield on REM Still Lost Investors Money: The Mortgage REIT Trap24/7 Wall Street · Oct 14, 2026
REM: Improving Fundamentals, But Caution Signs Remain (Upgrade)Seeking Alpha · Sep 8, 2026
These 3 High-Yield ETFs Cost You Thousands If You Hold Them in the Wrong Account24/7 Wall Street · Aug 28, 2026
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1GuruFocus · Aug 24, 2026
Rate Cuts Are Finally Here and These 3 Real Estate ETFs Pay Up to 10 Percent24/7 Wall Street · Aug 1, 2026The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the FTSE NAREIT Mortgage REITs Index. The Index measures the performance of the residential and commercial mortgage real estate sector of the U.S. equity market.